semaglutide issues Tirzepatide vs Semaglutide: What You Need to Know Beyond the Semaglutide Shortage: Emerging
Description
GLP-1 receptor agonists used to treat diabetes and obesity also may protect against eye diseases like age-related macular degeneration.
Diabetic Drugs Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, and Trulicity Sold as Weight-Loss Drugs Linked to Gastroparesis and Stomach Paralysis.
Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin
In consequence, following loss of exclusivity, semaglutide would face competition from biosimilars in Canada but generics in the United States
